RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Beijing Hotgen Biotech Co Stock

Beijing Hotgen Biotech Co P/E 2025

Beijing Hotgen Biotech Co P/E

-29.17

Ticker

688068.SS

ISIN

CNE100003P82

As of Jun 27, 2025, Beijing Hotgen Biotech Co's P/E ratio was -29.17, a -122.74% change from the 128.28 P/E ratio recorded in the previous year.

The Beijing Hotgen Biotech Co P/E history

Beijing Hotgen Biotech Co Aktienanalyse

What does Beijing Hotgen Biotech Co do?

Beijing Hotgen Biotech Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Beijing Hotgen Biotech Co's P/E Ratio

The Price to Earnings (P/E) Ratio of Beijing Hotgen Biotech Co is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Beijing Hotgen Biotech Co's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Beijing Hotgen Biotech Co is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Beijing Hotgen Biotech Co’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Beijing Hotgen Biotech Co stock

What is the price-to-earnings ratio of Beijing Hotgen Biotech Co?

The price-earnings ratio of Beijing Hotgen Biotech Co is currently -29.17.

How has the price-earnings ratio of Beijing Hotgen Biotech Co changed compared to last year?

The price-to-earnings ratio of Beijing Hotgen Biotech Co has increased by -122.74% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Beijing Hotgen Biotech Co high compared to other companies?

Yes, the price-to-earnings ratio of Beijing Hotgen Biotech Co is high compared to other companies.

How does an increase in the price-earnings ratio of Beijing Hotgen Biotech Co affect the company?

An increase in the price-earnings ratio of Beijing Hotgen Biotech Co would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Beijing Hotgen Biotech Co affect the company?

A decrease in the price-earnings ratio of Beijing Hotgen Biotech Co would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Beijing Hotgen Biotech Co?

Some factors that influence the price-earnings ratio of Beijing Hotgen Biotech Co are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Beijing Hotgen Biotech Co pay?

Over the past 12 months, Beijing Hotgen Biotech Co paid a dividend of 0.2 CNY . This corresponds to a dividend yield of about 0.15 %. For the coming 12 months, Beijing Hotgen Biotech Co is expected to pay a dividend of 0.2 CNY.

What is the dividend yield of Beijing Hotgen Biotech Co?

The current dividend yield of Beijing Hotgen Biotech Co is 0.15 %.

When does Beijing Hotgen Biotech Co pay dividends?

Beijing Hotgen Biotech Co pays a quarterly dividend. This is distributed in the months of July, July, July, August.

How secure is the dividend of Beijing Hotgen Biotech Co?

Beijing Hotgen Biotech Co paid dividends every year for the past 1 years.

What is the dividend of Beijing Hotgen Biotech Co?

For the upcoming 12 months, dividends amounting to 0.2 CNY are expected. This corresponds to a dividend yield of 0.15 %.

In which sector is Beijing Hotgen Biotech Co located?

Beijing Hotgen Biotech Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Beijing Hotgen Biotech Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Beijing Hotgen Biotech Co from 7/3/2024 amounting to 0.2 CNY, you needed to have the stock in your portfolio before the ex-date on 7/3/2024.

When did Beijing Hotgen Biotech Co pay the last dividend?

The last dividend was paid out on 7/3/2024.

What was the dividend of Beijing Hotgen Biotech Co in the year 2024?

In the year 2024, Beijing Hotgen Biotech Co distributed 3.378 CNY as dividends.

In which currency does Beijing Hotgen Biotech Co pay out the dividend?

The dividends of Beijing Hotgen Biotech Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Beijing Hotgen Biotech Co

Our stock analysis for Beijing Hotgen Biotech Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Beijing Hotgen Biotech Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.